نتایج جستجو برای: interferon therapy

تعداد نتایج: 712677  

Journal: :The New England journal of medicine 1998
G L Davis R Esteban-Mur V Rustgi J Hoefs S C Gordon C Trepo M L Shiffman S Zeuzem A Craxi M H Ling J Albrecht

BACKGROUND Interferon alfa is the only effective treatment for patients with chronic hepatitis C. Forty percent of patients have an initial response to this therapy, but most subsequently relapse. We compared the effect of interferon alone with that of interferon plus oral ribavirin for relapses of chronic hepatitis C. METHODS We studied 345 patients with chronic hepatitis C who relapsed afte...

Journal: :Cardiovascular Ultrasound 2005
Nicoline Jochmann Felix Kiecker Adrian C Borges Maja A Hofmann Stephan Eddicks Wolfram Sterry Gert Baumann Uwe Trefzer

BACKGROUND Interferon alpha2 is widely used in hepatitis and high-risk melanoma. Interferon-induced pulmonary arterial hypertension as a side effect is rare. CASE PRESENTATION We describe a melanoma patient who developed severe pulmonary arterial hypertension 30 months after initiation of adjuvant interferon alpha2b therapy. Discontinuation of interferon did not improve pulmonary arterial hyp...

2011
Cristina Popescu Victoria Arama Smaranda Gliga

BACKGROUND Cardio toxicity due to interferon therapy was reported only in small case series or case reports. The most frequent cardiac adverse effects related to interferon are arrhythmias and ischemic manifestations. The cardiomyopathy and pericarditis are rare but can be life threatening. The predisposing factors for interferon cardio toxicity were described only for ischemic manifestations a...

Journal: :Vestnik dermatologii i venerologii 2023

The choice of tactics for managing a patient with mycosis fungoides is determined by the stage disease. In early stages fungoides, treatment approach using external therapy and various ultraviolet irradiation spectra (UVB-311 nm PUVA therapy) preferable. With insufficient efficiency / or short remissions in some patients, it possible to use combined methods stages: UVB-311 therapy. combination ...

Journal: :Gut 2000
S W Schalm J Heathcote J Cianciara G Farrell M Sherman B Willems A Dhillon A Moorat J Barber D F Gray

UNLABELLED BACKGROUND, AIM, AND METHODS: Alpha interferon is the generally approved therapy for HBe antigen positive patients with chronic hepatitis B, but its efficacy is limited. Lamivudine is a new oral nucleoside analogue which potently inhibits hepatitis B virus (HBV) DNA replication. To investigate the possibility of an additive effect of interferon-lamivudine combination therapy compared...

Journal: :Journal of Ayub Medical College, Abbottabad : JAMC 2016
Amna Awan Muhammad Umar Hamama tul Bushra Khaar Afifa Kulsoom Zahid Minhas Saima Ambreen Nasir Habib Wasiq Mumtaz Farhan Habib

BACKGROUND Hepatitis is a major public health problem in Pakistan due to its strong association with liver failure and hepatocellular carcinoma. In Pakistan, conventional interferon therapy along with Ribavirin is favoured especially in Government funded programs for treatment of Hepatitis C, over the more expensive Pegylated Interferon and Ribavirin combination therapy as recommended by Pakist...

Journal: :Cancer research 1988
T Y Basham M A Palladino C C Badger I D Bernstein R Levy T C Merigan

Two murine models, C3H 38C13 B-cell lymphoma and AKR SL2 T-cell lymphoma were used to determine the efficacy of three different interferon preparations, recombinant human hybrid interferon-alpha A/D, recombinant murine interferon (rMIFN)-gamma, and natural MIFN-alpha/beta (greater than or equal to 85% beta), alone and in combination with tumor specific and nonspecific monoclonal antibody therap...

2000
A Moorat J Barber D F Gray S W Schalm J Heathcote J Cianciara G Farrell M Sherman B Willems A Dhillon

Background, aim, and methods—Alpha interferon is the generally approved therapy for HBe antigen positive patients with chronic hepatitis B, but its eYcacy is limited. Lamivudine is a new oral nucleoside analogue which potently inhibits hepatitis B virus (HBV) DNA replication. To investigate the possibility of an additive eVect of interferon-lamivudine combination therapy compared with interfero...

Journal: :acta medica iranica 0
keivan basiri neuroscience research center, isfahan university of medical sciences, isfahan, iran. and department of neurology, isfahan university of medical sciences, isfahan, iran. masood etemadifar neuroscience research center, isfahan university of medical sciences, isfahan, iran. and department of neurology, isfahan university of medical sciences, isfahan, iran. fatemeh derakhshan neuroscience research center, isfahan university of medical sciences, isfahan, iran. fereshteh ashtari neuroscience research center, isfahan university of medical sciences, isfahan, iran. and department of neurology, isfahan university of medical sciences, isfahan, iran. vahid shaygannejad neuroscience research center, isfahan university of medical sciences, isfahan, iran. and department of neurology, isfahan university of medical sciences, isfahan, iran. zahra fatehi neuroscience research center, isfahan university of medical sciences, isfahan, iran.

none of the approved immunomodulatory drugs in adults multiple sclerosis (ms) patients have been officially approved for the pediatric patients and are currently used off-label in this population. in this study, we evaluated the effectiveness and tolerability of intramuscular interferon beta1-a (avonex®) and subcutaneously injected interferon beta1-b (betaferon®) in children with definite relap...

2006
Teresa Y. Basham Michael A. Palladino Christopher C. Badger Irwin D. Bernstein Ronald Levy Thomas C. Merigan

Two murine models, C3H 38C13 B-cell lymphoma and AKR SL2 I cell lymphoma were used to determine the efficacy of three different Interferon preparations, recombinant human hybrid interferon-a A/D, recombinant murine Interferon (rMIFN)-7, and natural MIFN-a//3 (>85% ß), alone and in combination with tumor specific and nonspecific monoclonal antibody therapy. All three Interferon preparations hav...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید